Home Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population
Article
Licensed
Unlicensed Requires Authentication

Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population

  • Elianne A. Roelandse-Koop , Bert Buisman , Erik J. van Hannen , Anneke van der Zee , Wouter Kortlandt , Mirjam H.A. Hermans , Arend-Jan van Houte EMAIL logo and Rianne van Rhee-Luderer
Published/Copyright: September 6, 2011

Abstract

Background: Human leukocyte antigen B27 (HLA-B27) is strongly associated with ankylosing spondylitis. The B27 allele is present in 90% of patients with this disease, whereas it is present in only 9% of Caucasians. Molecular detection of HLA-B27 is traditionally based on allele specific amplification of exon 2 (Olerup method) or exon 3 (Dominguez method) by PCR, followed by gel analysis.

Methods: We developed a real-time TaqMan PCR based on the Dominguez method with a β-Globin PCR as internal control.

Results: A total of 544 clinical samples were used to compare the real-time TaqMan PCR with the traditional Dominguez PCR, the traditional Olerup PCR and a commercial Olerup based HLA-B27 detection kit (Olerup SSPTM HLA-B27, GenoVision). While 542 samples gave concordant results, two samples showed discrepancies and were further analyzed. One sample that showed a discrepancy was negative with the traditional Olerup method and positive with the three other procedures. Sequencing analysis showed the presence of HLA-B*2712 in this sample. The other sample, positive with both Olerup based PCRs and negative with both Dominguez based methods, turned out to be positive for HLA-B*2707 by sequence analysis.

Conclusions: With a correct result for 543 out of 544 samples (99.8%), we consider our real-time HLA-B27 PCR is a reliable method to detect HLA-B27 in the Dutch population, with reduced hands-on time and contamination risk compared to traditional PCR methods.


Corresponding author: Dr. Arend-Jan van Houte, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands Phone: +31-882506697, Fax: +31-882506695

Received: 2010-11-29
Accepted: 2011-8-1
Published Online: 2011-9-6
Published in Print: 2011-12-1

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorial
  2. Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety
  3. Reviews
  4. New insights into adipose tissue dysfunction in insulin resistance
  5. Role of biomarkers in cardioncology
  6. Minireviews
  7. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
  8. High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department
  9. Opinion Paper
  10. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?
  11. Guidelines and Recommendations
  12. The Greek way to the Register: the establishment and operation of the Register for Clinical Chemists-Clinical Biochemists in Greece
  13. Genetics and Molecular Diagnostics
  14. Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population
  15. General Clinical Chemistry and Laboratory Medicine
  16. Results of the recalibration of creatinine measurement with the modular Beckman Coulter® Jaffe creatinine method
  17. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  18. Oxidative status in the lungs associated with tobacco smoke exposure
  19. Correlation of cortisol in 1-cm hair segment with salivary cortisol in human: hair cortisol as an endogenous biomarker
  20. Evaluation of the MassTrak Immunosuppressant XE Kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards
  21. Simultaneous determination of cyclophosphamide and 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry – application to Chinese systemic lupus erythematosus patients
  22. Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience
  23. Chemistry and haematology sample rejection and clinical impact in a tertiary laboratory in Cape Town
  24. Trefoil factor family peptides are increased in the saliva of children with mucositis
  25. Validation of commercial assays for measurements of trefoil factor family peptides in serum
  26. To mix or not to mix venous blood samples collected in vacuum tubes?
  27. Rapid and simple IgG specific test for the exclusion of heparin induced thrombocytopenia (HIT)
  28. β-Thalassemia mutations in subjects with borderline HbA2 values: a pilot study in North India
  29. Cancer Diagnostics
  30. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers
  31. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
  32. Infectious Diseases
  33. Measurement of granulocyte maturation may improve the early diagnosis of the septic state
  34. Cardiovascular Diseases
  35. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature
  36. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis
  37. Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects
  38. Diabetes
  39. The optimal cut-points of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in the Chinese population living in Sichuan
  40. Letters to the Editor
  41. Specimen labelling: before or after collection?
  42. Effect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels
  43. Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring
  44. Acknowledgement
  45. Acknowledgement
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.252/html
Scroll to top button